TICKERNERD
Menu
OPCHOPCHHealthcare · Medical Care Facilities

OPCH Stock Forecast: Option Care Health, Inc. Price Predictions for 2026-2027

Last close, 24 Sept 2026
$23
−1.71% on the day

The 13 Wall Street analysts covering Option Care Health, Inc. hold a median 12-month price target of $28 — +22.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 84 of 100 as at 23 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$3.6B
Ticker Nerd rank
84 / 100
Median analyst target
$28
Analysts covering
13
Revenue$1.4B+1.9% y/y
Operating income$85.1M
Net income$53.9M
Free cash flow$172.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−6.4%
1M
−3.1%
YTD
−28.0%
1Y
−16.6%
From 52W high
−37.3%
From 52W low
+17.5%
$20
$37
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

OPCH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Option Care Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 23 Sept 2026
84 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
93
Volatility
89
Revisions
88
Issuance
75
Accruals
71
Quality
68
Growth
51
Size
27
Momentum
25

Value (93): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (25): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

OPCH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on OPCH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$20$25$30$35$40Oct 25Jan 26Apr 26Jul 26OPCHHigh $39Median $28Low $23

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says13 analysts
8 Buy5 Hold0 Sell
Low $23Median $28High $39

The green dot is the last close — the median target sits +22.1% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
30 July 2026Deutsche BankDowngradeHold$26 → $24
17 July 2026Stephens & Co.DowngradeEqual-Weight$30 → $24
17 July 2026Stephens & Co.DowngradeEqual-Weight—
8 June 2026Goldman SachsInitiatesNeutral$22
8 June 2026Goldman SachsInitiatesNeutral—
6 May 2026Morgan StanleyMaintainsOverweight—
4 May 2026JP MorganMaintainsOverweight—
1 May 2026Barrington ResearchMaintainsOutperform—
1 May 2026TD CowenMaintainsHold—
1 May 2026UBSMaintainsBuy—
16 Jan 2026Barrington ResearchMaintainsOutperform—
13 Jan 2026CitizensReiteratesMarket Outperform—
13 Jan 2026Morgan StanleyMaintainsOverweight—
11 Dec 2025Stephens & Co.InitiatesOverweight—
9 Dec 2025B of A SecuritiesMaintainsBuy—
9 Dec 2025Deutsche BankMaintainsBuy—
3 Nov 2025TD CowenMaintainsHold—
31 Oct 2025Barrington ResearchMaintainsOutperform—
31 Oct 2025CitizensMaintainsMarket Outperform—
17 Oct 2025Morgan StanleyInitiatesOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. OPCH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

OPCH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 24 Sept 2026, Option Care Health, Inc. returned −16.6% against +17.3% for the S&P 500, dividends included.

OPCH vs S&P 500, last 12 monthsTotal return, rebased to 100
708090100110120130Oct 25Jan 26Apr 26Jul 26OPCHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

OPCH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+2.2%
Analysts raising
11
Analysts cutting
0
Fundamentals

Option Care Health, Inc. (OPCH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
18.1×

Cheaper than 40% of US stocks

Price / sales
0.6×

Cheaper than 78% of US stocks

Price / book
2.8×

Cheaper than 34% of US stocks

EV / EBITDA
11.5×

Cheaper than 32% of US stocks

Growth & margins
Revenue growth (YoY)
1.9%

Higher than 32% of US stocks

Earnings growth (YoY)
6.7%

Higher than 43% of US stocks

Gross margin
18.5%

Higher than 19% of US stocks

Operating margin
5.9%

Higher than 57% of US stocks

Net margin
3.7%

Higher than 57% of US stocks

Returns & dividend
Return on equity
16.0%

Higher than 76% of US stocks

Return on assets
6.2%

Higher than 82% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Option Care Health, Inc. (OPCH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Option Care Health, Inc. has a market value of $3.6B and an enterprise value of $4.7B.

  • Revenue in the twelve months to 30 June 2026: $5.7B. The latest quarter grew 1.9% year on year.

  • Net income over the same four quarters: $209.6M, a 3.7% net margin.

  • Diluted earnings per share, trailing twelve months: $1.33.

  • Free cash flow in the twelve months to 30 June 2026: $303.8M.

  • Option Care Health, Inc. spent $328.1M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 149.8M.

  • Trailing P/E: 18.1×; forward P/E: 11.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Option Care Health, Inc. employs 8,000 people — $712K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 23 Sept 2026

Data provided by Twelve Data

Peers

OPCH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
OPCHOption Care Health, Inc.$3.6B
84
NHCNational HealthCare Corp.$3.5B
67
CONConcentra Group Holdings Parent, Inc.$4.4B
96
LFSTLifestance Health Group, Inc.$4.7B
93
AVAHAveanna Healthcare Holdings, Inc.$2.8B
88
GRDNGuardian Pharmacy Services, Inc.$2.7B
79
BKDBrookdale Senior Living, Inc.$2.7B
75

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Option Care Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest OPCH news & analysis

Option Care Health, Inc. (OPCH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha · 15 Sept 2026neutral

Option Care Health, Inc. presented at the Morgan Stanley 24th Annual Global Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The item reports on the company's participation in the investor conference.

Why it matters — An OPCH watcher would care because the conference presentation gives investors insight into the company's business and strategy directly from its leadership.

Should Value Investors Buy Option Care Health (OPCH) Stock?

Zacks Investment Research · 7 Sept 2026neutral

Zacks Investment Research published an article examining whether value investors should consider Option Care Health (OPCH) stock, framing the analysis within its Zacks Rank system that emphasizes earnings estimates and revisions while also tracking value, growth, and momentum trends.

Why it matters — A OPCH watcher would care because this reflects how a major research firm is evaluating the stock's investment profile and placing it within broader market screening.

Option Care Health to Participate in Upcoming Investor Conferences

GlobeNewsWire · 2 Sept 2026neutral

Option Care Health announced that CEO John Rademacher and CFO Meenal Sethna will participate in upcoming investor conferences, as reported in a company press release.

Why it matters — The company's leadership participation in investor conferences offers OPCH watchers an opportunity to hear directly from top executives about the business.

4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds

Zacks Investment Research · 28 Aug 2026positive

Zacks Investment Research highlighted the Medical - Outpatient and Home Healthcare industry as benefiting from an aging population, growing telehealth adoption, and AI use. The article identified DVA, LFST, OPCH, and AVAH as companies positioned to benefit from these tailwinds.

Why it matters — OPCH was named among companies expected to benefit from supportive industry trends, which is notable for investors tracking the stock.

OPCH or CHE: Which Is the Better Value Stock Right Now?

Zacks Investment Research · 25 Aug 2026neutral

A Zacks Investment Research article compares Option Care (OPCH) and Chemed (CHE) as potential value stock opportunities within the Medical - Outpatient and Home Healthcare sector, examining which of the two offers the better value right now.

Why it matters — OPCH watchers would care because the piece directly evaluates how Option Care stacks up as a value investment against a sector peer.

FAQ

Frequently asked questions about OPCH stock

What is the OPCH stock price forecast for 2026-2027?

The 13 Wall Street analysts covering Option Care Health, Inc. have a median 12-month price target of $28, with estimates ranging from $23 to $39. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is OPCH stock a buy right now?

Of the 13 analysts covering Option Care Health, Inc., 8 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Option Care Health, Inc. 84 out of 100 across roughly 4,600 US stocks as at 23 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank OPCH?

As at 23 Sept 2026, Option Care Health, Inc. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (93 of 100).

Will OPCH stock go up?

No one can know that. What the data says: the median 12-month target from 13 analysts implies +22.1% from the last close, and Ticker Nerd's factor model ranks Option Care Health, Inc. 84 out of 100 as at 23 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the OPCH stock forecast for 2030?

No analyst covering Option Care Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for OPCH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $23 to $39 over the next 12 months.

How has OPCH stock performed over the past year?

Option Care Health, Inc. returned -16.6% over the 12 months to 24 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Option Care Health, Inc. do?

Option Care Health Inc. is a healthcare services company that provides home and alternate site infusion therapy across the United States.

What is the latest news on OPCH?

The most recent item we track (Seeking Alpha, 15 Sept 2026): "Option Care Health, Inc. (OPCH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript". Option Care Health, Inc. presented at the Morgan Stanley 24th Annual Global Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The item reports on the company's participation in the investor conference.

Company

About Option Care Health, Inc.

Option Care Health Inc. is a healthcare services company that provides home and alternate site infusion therapy across the United States. The company delivers medications and clinical support for patients who need intravenous or injectable treatments outside the hospital, including therapies for infections, immune deficiencies, chronic inflammatory disorders, nutrition support, and other acute or chronic conditions. Its services combine pharmacy coordination, nursing care, treatment monitoring, and care coordination to support patients in home settings and ambulatory infusion suites. Option Care Health works with physicians, hospitals, payers, and other referral sources to manage complex infusion regimens through a national network of pharmacies and infusion locations. The company plays an important role in post-acute care by helping shift appropriate treatment to lower-acuity settings while maintaining clinical oversight and continuity of care.

CEO Mr. John Charles Rademacher · 8,000 employees · United States · https://optioncarehealth.com